157 Results for "

coagulation factor

" in MedChemExpress (MCE) Product Catalog:
Products (157)

157 Results for "coagulation factor" in MCE Product Catalog:

61
61 Publications Verification
Referencia número: HY-17567A
No. CAS: 9041-08-1
Synonyms: Sodium heparin; Sodium heparinate
Áreas de investigación:  

Cardiovascular Disease Cancer

Heparin sodium salt (Sodium heparin) is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa. Heparin sodium salt significantly inhibits exosome-cell interactions.
loading...
    loading...
20
20 Cited Publications
Referencia número: HY-145405
No. CAS: 1220890-25-4
Pureza:  99.91%
C12-200 is a type of ionizable cationic lipid and helper lipid commonly used for mRNA delivery. In the hemophilia B mouse model, mRNA encoding human erythropoietin (EPO) and coagulation factor IX (FIX) can be successfully delivered and expressed using C12-200. C12-200 is utilized in research related to hemophilia B .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-P1929
No. CAS: 128270-60-0
Bivalirudin, a hirudin analog and anticoagulant, is a direct thrombin inhibitor. Bivalirudin inhibits thrombin-mediated fibrinogen cleavage, coagulation factor activation, and platelet activation by reversibly binding to thrombin. In addition, Bivalirudin also has certain effects of anti-virus, anti-inflammation, and vascular endothelial barrier function protection. Bivalirudin can be used for the research of thrombotic diseases and others .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-15664
No. CAS: 1191386-55-6
Pureza:  99.89%
Bivalirudin TFA, a hirudin analog and anticoagulant, is a direct thrombin inhibitor. Bivalirudin TFA inhibits thrombin-mediated fibrinogen cleavage, coagulation factor activation, and platelet activation by reversibly binding to thrombin. In addition, Bivalirudin TFA also has certain effects of anti-virus, anti-inflammation, and vascular endothelial barrier function protection. Bivalirudin TFA can be used for the research of thrombotic diseases and others .
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-114164H
No. CAS: 9002-04-4
Synonyms: EC 3.4.21.5 (Lyophilized); Human Alpha Thrombin (Lyophilized)
Human α-Thrombin (EC 3.4.21.5; Human Alpha Thrombin) (Lyophilized) is a terminal serine protease in the coagulation cascade, as well as a potent physiological platelet agonist and fibrin-generating enzyme in vivo. Human α-Thrombin catalyzes the conversion of fibrinogen to fibrin for blood clot formation, and activates platelet aggregation by cleaving the protease-activated receptors PAR1 (major) (Kd = 1 nM) and PAR4 (minor) on the platelet surface to expose tethered ligands. Human α-Thrombin also amplifies coagulation via positive feedback by activating coagulation factors V, VIII, XI (FV/FVIII/FXI), and switches to activate protein C to exert anticoagulant effects after binding to thrombomodulin .
This product is in a freeze-dried form.
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-10264
No. CAS: 480449-70-5
Pureza:  99.81%
Synonyms: DU-176
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Ki values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research .
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-10264A
No. CAS: 480449-71-6
Pureza:  99.84%
Synonyms: DU-176b
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) tosylate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban tosylate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban tosylate can be used for preventing thromboembolic disease research .
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-10264B
No. CAS: 1229194-11-9
Pureza:  99.97%
Synonyms: DU-176b monohydrate
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) monohydrate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban monohydrate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban monohydrate can be used for preventing thromboembolic disease research .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-137431
No. CAS: 2064121-65-7
Pureza:  99.80%
Synonyms: BAY-2433334
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Asundexian (BAY 2433334) is an orally active coagulation factor Xia (FXIa) inhibitor. Asundexian binds directly, potently, and reversibly to the active site of FXIa and thereby inhibits its activity. Asundexian inhibits human FXIa in buffer with an IC50 of 1 nM .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-B0385
No. CAS: 56974-61-9
Synonyms: FOY
Target:  

Proteasome Factor Xa

Áreas de investigación:  

Inflammation/Immunology

Gabexate mesylate (FOY) is is a competitive and non-antigenic synthetic inhibitor of trypsin-like serine proteinases. Gabexate mesylate inhibits human thrombin, urokinase, plasmin, and Factor Xa with Kis of 0.97, 1.3, 1.6, and 8.5 μM, respectively. Gabexate mesylate binds to human and bovine tryptase with Kis of 3.4 nM and 18 μM, respectively. Gabexate mesylate exerts an anticoagulant effect on the clotting activity of thrombin and has anti-inflammatory effect by viainhibition of NF-κB, proinflammatory cytokines, and nitric oxide. Gabexate mesylate is used for pancreatitis and disseminated intravascular coagulation .
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-17567C
No. CAS: 9041-08-1
Synonyms: Sodium heparin (MW 15kDa); Sodium heparinate (MW 15kDa)
Áreas de investigación:  

Cardiovascular Disease

Heparin sodium salt (MW 15kDa) (Sodium heparin (MW 15kDa)) is a polymer of Heparin with the molecular weight of 15kDa. Heparin sodium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-112624
No. CAS: 9004-54-0
Synonyms: Dextran 40
Dextran (Dextran 40) has an inhibitory effect on thrombocyte aggregation and coagulation factors and is used as a plasma volume expander.
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-125856
No. CAS: 1802425-99-5
Pureza:  99.93%
Synonyms: BMS-986177; JNJ-70033093
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Milvexian is an orally bioavailable, small-molecule, reversible, direct antagonists of factor Xia, with the Ki of 0.11, 0.38, 0.64, 490, 350 nM for human, rabbit, dog, rat, mouse, respectively. Milvexian shows anti-thrombosis activity in vitro and in vivo, and can be used for thrombus study .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P4245
No. CAS: 88546-74-1
Target:  

Factor Xa Kallikrein

Áreas de investigación:  

Cardiovascular Disease Neurological Disease

D-Pro-Phe-Arg-Chloromethylketone, a inhibitor of coagulation factor XII and plasma kallikrein, plays an important role in thrombosis and inflammation .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P991124
No. CAS: 3008610-21-4
Synonyms: REGN-7508

Target:  

Factor XI

Áreas de investigación:  

Cardiovascular Disease

Cenvacibart is a monoclonal antibody with anticoagulant activity, targeting human coagulation factor XI (F11). Cenvacibart blocks the role of coagulation factor XI in the coagulation cascade, reducing thrombus formation. Cenvacibart is promising for research of thrombotic diseases .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P991117
No. CAS: 3008610-20-3
Synonyms: REGN-9933

Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Amrecibart is an anti-coagulation factor 11 human IgG4 κ monoclonal antibody. Recommend Isotype Controls: Human IgG4 kappa, Isotype Control (HY-P99003) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P701216
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: F2; coagulation factor II (Thrombin); coagulation factor II, Thrombin; Prothrombin B-Chain; Prothrombin; F2 Protein; Prepro-coagulation factor II; RPRGL2; coagulation factor II; THPH1; Thrombin factor II; PT
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P7860
Pureza:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: F10; Prothrombinase; coagulation factor X; factor Xa; Stuart-Prower factor; factor X; Stuart factor; FXA; FX
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P70231
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: F9; Autoprothrombin IIA; coagulation factor IX; Coagulant factor IX; FIX; Christmas Disease; Plasma Thromboplastic Component; Hemophilia B; Plasma Thromboplastin Component; factor IX F9; Christmas factor; factor IX; PTC; factor 9; Truncated coagulation Fa
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P74238
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: F13B; Fibrin-Stabilizing factor B Subunit; coagulation factor XIII B Chain; Transglutaminase B Chain; FXIIIB; Alternative Protein F13B; Protein-Glutamine Gamma-Glutamyltransferase B Chain; TGase; coagulation factor XIII, B Polypeptide
Species:  
Source:  
loading...
    loading...